MED Platform III SCSp is a private equity fund based in Luxembourg, Luxembourg. According to its most recent Form D, filed Aug 14, 2026, it has sold $2,108,062,428 of interests to 139 investors since its first sale in Aug 2026. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Jaime Gomez-Ferrer; Archimed Sas; Jeppe Lindgaard.
- Total raised
- $2,108,062,428Cumulative sales reported on Form D
- Investors
- 139
- First sale
- Aug 3, 2026
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Jaime Gomez-Ferrer; Archimed Sas; Jeppe Lindgaard
- Latest Form D
- Aug 14, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about MED Platform III SCSp
What is the minimum investment for MED Platform III SCSp?
MED Platform III SCSp's latest Form D, filed Aug 14, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in MED Platform III SCSp?
MED Platform III SCSp is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has MED Platform III SCSp raised?
MED Platform III SCSp reports $2,108,062,428 sold from 139 investors on its Form D filed Aug 14, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is MED Platform III SCSp based?
MED Platform III SCSp is based in Luxembourg, Luxembourg and is managed by Archimed.
When did MED Platform III SCSp launch?
MED Platform III SCSp reports its first sale in Aug 2026.
Size compared with every private equity fund
Raised more than 92% of the 577 private equity funds based in Luxembourg, and more than 97% of all 8,896 that report sales.